Crumbs21 Mar 2021 07:33
Thanks for that, I hadn’t seen it before and indeed Nottingham University is ‘on the map’ ..
The challenge is a very large one. Many of those ‘pushes’ are still looking ... Nottingham has a product! Targeting intercellular structures certainly isn’t as straight forward as targeting surface structures ... question is, can Immunobody / avidimab do it! And if it does, value immunobody / avidimab....
Take care all ..